You are here

Anti-inflammatory Drugs May Help With Depression

Antibiotics, Statins, and Glucocorticoids All Show Promise

In the largest meta-analysis ever carried out, researchers from Aarhus University and Aarhus University Hospital, Psychiatry, have shown that medicine that inhibits inflammation, such as arthritis drugs, can also be effective in the treatment of depression.

The analysis is based on 36 international placebo-controlled studies with a total of 9,422 patients who either suffered from depression or had depressive symptoms. The results have been published in Acta Psychiatrica Scandinavica.

In addition to looking into arthritis drugs, the researchers also examined the effect of other forms of medication that have an anti-inflammatory effect, including glucocorticoids and the antibiotic minocycline, adrenocortical hormone and statins, all of which showed antidepressant effects. The biggest challenge with depression, the researchers point out, is that we still do not know what triggers the disease in a particular individual.

According to Ole Köhler-Forsberg, one of the researchers, "Some studies suggest that the choice of antidepressant can be decided by a blood sample that measures whether there is an inflammatory condition in the body. Other studies show that the same blood sample can be used as a guideline for whether a depressive patient can be treated with anti-inflammatory medicine that has a better effect when there is inflammation present at the same time as the depression. However, we need to verify these findings and examine which patients can benefit from this before it can be implemented in everyday clinical practice," Köhler-Forsberg says.

In many of the studies conducted to date, the depressive symptoms were a secondary goal, meaning that large-scale and well-executed studies with depression as the primary objective are still needed.

Source: Medical Xpress, April 9, 2019

Recent Headlines

Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs